{"name":"Candid Therapeutics","slug":"candid-therapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxQb2NqVFY5RXU4bFZqdDZPcFo3ZURLUHl6QmphaUNlcG5pNGR0ZzlzRk9oZHhHR3hwS3h6TjJrSFpCYVM0NF9jUmloZGdzcEVZSHpyN19lcXFhSjNmQnFWODJURVliUlRRXzhyRmlYZWh4UkVyMzc4bEVwcVF1aWxHMk9EQkp1RFRvNWNtZUVibFFPcEQxaUNTUkE0TGtNZElJcGJDXy0yODM?oc=5","date":"2026-03-04","type":"deal","source":"The Pharma Letter","summary":"Candid lists via Rallybio reverse merger, adds $505m financing - The Pharma Letter","headline":"Candid lists via Rallybio reverse merger, adds $505m financing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxNcEQtMHA0ZTBKMjJLeDcxTXpJSkg1cVZYRTBNNXVrOXBrVk5MN0pZUGpsWXd4UmZXem5JUnR2TG8tU081NXY4Q3NVVjVQYzlnbUpZYVJmQ1dxZ1ljVDZQcXpGZDdsenM1Nkd3MUM3VFE0aHpTZFBBODVqSGlkOXJ1Z0themVYdV9JWThMVTFEUGY?oc=5","date":"2026-03-03","type":"deal","source":"Pharmaceutical Technology","summary":"Rallybio to acquire Candid Therapeutics - Pharmaceutical Technology","headline":"Rallybio to acquire Candid Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxOVzZnSkZOMEhUY0xuWWN2YS1IRnJnT0gxTUdqYnF3eThrRm04STNJMTNkZHpfQTVUdU5mQ1J1WU5yZWNYX09GX2RRNTJlRkhVRlM5d1I0R3VFYjlvbUtRSmYtdWxXdkZDWUcyS054QU9FcEs2NGpCMHJIakh4eERYLWpaVS1yWDNvZDBEMlRGM0k5cm8?oc=5","date":"2026-03-02","type":"deal","source":"BioPharma Dive","summary":"Candid, in a reverse merger with RallyBio, to go public - BioPharma Dive","headline":"Candid, in a reverse merger with RallyBio, to go public","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxOb09HNUNEQkR2aTFZWW1MVU9QZDRoS3dXaXVUMzJPNkNTTVl0YjZsQmRpalZnUjJ0OHZ0NDJPMVdKbnpSS3BJN2ZFUGZhZS10bHFOb0V3OGVFT0hNcXdBZHFLRlpYNE0zYmNFc1kxUVYxUVRnZVRfYXZUT3Jhem12anV0QXU2S2J2bC1mRDVDM25GOENpOWJoMHFMNm5DamNRN1d0UzlyRkQ5RFBzU0FSZHl2bndDSjVRWktJMmx2ZXU?oc=5","date":"2026-03-02","type":"deal","source":"Fierce Biotech","summary":"TCE biotech Candid scores Nasdaq listing via reverse merger with rare disease-focused Rallybio - Fierce Biotech","headline":"TCE biotech Candid scores Nasdaq listing via reverse merger with rare disease-focused Rallybio","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxNSndrY2E3b1NYZHBnYmpwd19mZnZIdGdYUWlBLXJzX1dfTHcwNFBXU2E3SHA1ckxUN3NpOUk4VWhmQXc1X3UtRGNKZ3RXUnltdFg0UHhNZ2VfZVV3dkpfcDZNQk41SDFOWlpmWlZ2MDZnaS1VbTlsSUU4OGllVTFHVk80T00tcXpvVXR3QllxUXRmOVNURzZKckh0cjBlc3V3V2xrLXhLdUZldFY3QmlJX2thRHFrV2RtMDBsVzctWHQ?oc=5","date":"2026-03-02","type":"deal","source":"MedCity News","summary":"Candid Therapeutics Strikes Up Merger With Rallybio to Advance Its Autoimmune Drug Pipeline - MedCity News","headline":"Candid Therapeutics Strikes Up Merger With Rallybio to Advance Its Autoimmune Drug Pipeline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE00bDRqWHFqdi1IbWZidkdvR0VyeWhKUU1MQ1dpNnpKWkVZck9qMmRiX0dReTJUR3g0dGU3d1VycXlNTEhZdzk1bFB5Wl9xUFk2OXFz?oc=5","date":"2026-03-02","type":"trial","source":"FirstWord Pharma","summary":"Biopharma bites: More ACIP members, a public path for Candid, plus Novo's manufacturing boost and Aardvark's study pause - FirstWord Pharma","headline":"Biopharma bites: More ACIP members, a public path for Candid, plus Novo's manufacturing boost and Aardvark's study pause","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxNNjZDWU8tV2htdTJiWUtqMVdhZlJURnBObFN0aTU0cm9qMENLMERBeDRCdm5QeVBwb2NrMHI5ekduVjFQWFI4SkdOTW5fbzRxcDA0MFVUdWJwQmlPNU16T0cyQVBmbUlsVms2bWtMYnA4OGtmZm03bk5YeDFuSjVzSS1NMmxRUC1DdUVyM3M2eWkzQXA1OGF2cGpZbVd6TnVKRnZqN2UyWEtwRmxPY3NSeXZ2NUNtTE4w?oc=5","date":"2026-02-25","type":"pipeline","source":"San Diego Union-Tribune","summary":"‘It’s a wake-up call’: U.S. biotechs discuss why we’ve fallen behind China - San Diego Union-Tribune","headline":"‘It’s a wake-up call’: U.S. biotechs discuss why we’ve fallen behind China - San Diego Union","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxQTUVhd0RKX0pObm16cTVyQVBlalJPcXhaVWU5R0pqb0hrX1hKcWN5UW5DNEprQUxJajBaMDd4SXVoZEJNc1llWkxkS29xeS04aGlkaTIydV9DZFJpOXplZjJxMGR4MUYtbmR6NXU1elhqUElacGhpMDFFbl9YQ2lDOVMtNU0tZG5DU0lnUE4tdjhJa0pqTWpxNA?oc=5","date":"2026-02-09","type":"deal","source":"BioPharma Dive","summary":"Lilly buys ‘in vivo’ CAR-T maker Orna, extending streak of genetic medicine deals - BioPharma Dive","headline":"Lilly buys ‘in vivo’ CAR-T maker Orna, extending streak of genetic medicine deals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxOdXpCVGlhMkl0WDNvc0lqeW81eVJMa3dCQjMxdi1rVjMxYWVaM2U5U0xYYmFxbGZFaklnYTJTd0FKZ2pBRkZPU3BhaHN0SGJpTW5NR2FpR2ZPS1ZTNWV2RktBWHJwZDdpaG9BeXhhOVJJUVRlTzk2M254SjA4OXpRMWxpQnkxWFV2RS1oajlWTEg?oc=5","date":"2025-08-17","type":"pipeline","source":"finance.yahoo.com","summary":"Recursion Pharmaceuticals (RXRX) Expands AI Drug Discovery Pipeline with New Clinical Candid - finance.yahoo.com","headline":"Recursion Pharmaceuticals (RXRX) Expands AI Drug Discovery Pipeline with New Clinical Candid","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4wFBVV95cUxQRjE3WUhMbEJOclNiVzJWUHg1XzMxRHA3d085Wi1LYmlkaXV3b1ExUmIxdlJhdHNMNm9FTU5uNkN2WnRsalNyenk4bTFFWkV6VXcza3pKMXhQMUl3TzJfUEFPaFJCSmlRZWQzLUdYRVJ3bktpY3R2WkUycGpkUzBMVWFReUtsZlNXRUwxbGxETi1IWEMzN1Z4WmJMWkFXam1kQzhSYjdnY1RsYTdVMGRCVlZPQXpYTDU5X2JEVTgtVlVoZWF5eWVTZDVoZUNaSFc4UDBDdTVCcERxcUU4R2Vza3JlNA?oc=5","date":"2025-05-29","type":"deal","source":"PharmaLive","summary":"Jay Glazer and Wife Rosie Glazer offer candid look at ADHD and relationships in partnership with Supernus Pharmaceuticals - PharmaLive","headline":"Jay Glazer and Wife Rosie Glazer offer candid look at ADHD and relationships in partnership with Supernus Pharmaceutical","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9AFBVV95cUxNNElUUnNpUzZVdTEweHhUbFJuQy1GUEhCUC1yVmEyUWpIdXg1czRtbWU4Ty04cm5EUW1yMnB3VXZCWlRONzVJaFQ0RUZkMlVEMTE2aGIxVGx3TjBXQnpYcVdSWFptYVdDYlVmdHFoaW5fS0F1QVVHUDJlazhVRFFEZEtwLVNzR3R3Y1RXOXY0MVdNSVo2bjRQQ204VlRQZFdsYlFnaUUyM2tMRDh3NU9McFF5ZlBEcEV6YVRNa2JMU2w2SHB0QlMxTkgxWEl0TXJPU19pbnZxelFHc2tqelJpU3ZuNkxkZnlnbllxTmRFcWlmelBH?oc=5","date":"2024-10-17","type":"pipeline","source":"BioSpace","summary":"Candid Therapeutics Appoints Highly Accomplished Industry Leaders Angie You, Ph.D. and Dan Puckett to it’s Board of Directors - BioSpace","headline":"Candid Therapeutics Appoints Highly Accomplished Industry Leaders Angie You, Ph.D. and Dan Puckett to it’s Board of Dire","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgJBVV95cUxNU25KOHlFYUtBaEg0UjJlS2hOYzJWcHhDbDE2X1U5QXNOZVhzRFU1ZWp5X19IWnQzbkVDSG1qRVlLQ0N3a05CU1VPU1RLUHVGeWN2dTljWFFnYjBXUENaSm5tUXZieUtjZGtIZzI4YU1WNWVweDFGRUt5SUhWYzJfTklCV1JSalZkcXFWY3ByUXF1Wm5MYVFiLWxrbzJvZjZoQ1pvQUlqRzVwMU4zVXp5Zlp3TWIxQ25zVjhrNERXMXlvTVNOc0F4VWhiSlVFTFVxSHNUbFY2RjdSMjdSZmVybms3bG16emRnd2NLTzB1RGtrbkd2UG8xQlpITjQ2RldPaTg2QXlNUnV2T1dHaEE?oc=5","date":"2024-09-09","type":"pipeline","source":"Business Wire","summary":"Candid Therapeutics Debuts with $370M Capital Raise to Clinically Evaluate Potentially Transformative Autoimmune Therapies - Business Wire","headline":"Candid Therapeutics Debuts with $370M Capital Raise to Clinically Evaluate Potentially Transformative Autoimmune Therapi","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}